A Machine-Learning Prognostic Model for Colorectal Cancer Using a Complement-Related Risk Signature
Oncology Research · 2025
DOI: 10.32604/or.2025.066193 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Research, 2025. Verfasst von Jun Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Machine Learning, Biomarkers, Tumor, Complement System Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Objectives
Colorectal cancer (CRC) remains a major contributor to global cancer mortality, ranking second worldwide for cancer-related deaths in 2022, and is characterized by marked heterogeneity in prognosis and therapeutic response. We sought to construct a machine-learning prognostic model based on a complement-related risk signature (CRRS) and to situate this signature within the CRC immune microenvironment.
Methods
Transcriptomic profiles with matched clinical annotations from TCGA and GEO CRC cohorts were analyzed. Prognostic CRRS genes were screened using Cox proportional hazards modeling alongside machine-learning procedures. A random survival forest (RSF) predictor was trained and externally validated. Comparisons of immune infiltration, mutational burden, pathway enrichment, and drug sensitivity were made between risk groups. The function of FAM84A, a key model gene, was examined in CRC cell lines.
Results
The six-gene CRRS model accurately stratified patients by survival outcomes. Low-risk patients exhibited greater immune cell infiltration and higher predicted response to immunotherapy and chemotherapy, while high-risk patients showed enrichment of complement activation and matrix remodeling pathways. FAM84A was shown to promote CRC cell proliferation, migration, and epithelial-mesenchymal transition.
Conclusion
CRRS is a critical modulator of the CRC immune microenvironment. The developed model enables precise risk prediction and supports individualized therapeutic decisions in CRC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Vascular Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, China.
- Department of Medical Record Management, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, China.
- Department of Gastrointestinal Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, China.
Zitieren
APA
Li, J., Yu, K., Chen, Z., Xing, D., Zha, B., Xie, W., Ouyang, H., & Yu, C. (2025). A Machine-Learning Prognostic Model for Colorectal Cancer Using a Complement-Related Risk Signature. Oncology Research. https://doi.org/10.32604/or.2025.066193
Vancouver
Li J, Yu K, Chen Z, Xing D, Zha B, Xie W, et al. A Machine-Learning Prognostic Model for Colorectal Cancer Using a Complement-Related Risk Signature. Oncology Research. 2025. doi:10.32604/or.2025.066193
BibTeX
@article{Li2025,
author = {Li, Jun and Yu, Kangmin and Chen, Zhiyong and Xing, Dan and Zha, Binshan and Xie, Wentao and Ouyang, Huan and Yu, Changjun},
title = {A Machine-Learning Prognostic Model for Colorectal Cancer Using a Complement-Related Risk Signature},
journal = {Oncology Research},
year = {2025},
doi = {10.32604/or.2025.066193}
}
EUVIMED